Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6

Küffer, Alexander, Lakkaraju, Asvin , Doucerain, Cédric , Monnard, Arnaud , Schiavi, Carmen , Airich, Kristina , Grosshans, Bianka, Hornemann, Simone , Bassilana, Frederic and Aguzzi, Adriano (2016) The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6. Nature, 536 (7617). pp. 464-468. ISSN 14764687


Ablation of the cellular prion protein PrPC leads to a chronic demyelinating polyneuropathy affecting Schwann cells. Neuron-restricted expression of PrPC prevents the disease, suggesting that PrPC acts in trans through an unidentified Schwann cell receptor. Here we show that the cAMP concentration in sciatic nerves from PrPC -deficient mice is reduced, suggesting that PrPC acts via a G protein-coupled receptor (GPCR). The amino-terminal flexible tail (residues 23-120) of PrPC triggered a concentration-dependent increase in cAMP in primary Schwann cells, in the Schwann cell line SW10, and in HEK293T cells overexpressing the GPCR Adgrg6 (also known as Gpr126). By contrast, naive HEK293T cells and HEK293T cells expressing several other GPCRs did not react to the flexible tail, and ablation of Gpr126 from SW10 cells abolished the flexible tail-induced cAMP response. The flexible tail contains a polycationic cluster (KKRPKPG) similar to the GPRGKPG motif of the Gpr126 agonist type-IV collagen. A KKRPKPG-containing PrPC -derived peptide (FT 23-50) sufficed to induce a Gpr126-dependent cAMP response in cells and mice, and improved myelination in hypomorphic gpr126 mutant zebrafish (Danio rerio). Substitution of the cationic residues with alanines abolished the biological activity of both FT 23-50 and the equivalent type-IV collagen peptide. We conclude that PrPC promotes myelin homeostasis through flexible tail-mediated Gpr126 agonism. As well as clarifying the physiological role of PrPC, these observations are relevant to the pathogenesis of demyelinating polyneuropathies - common debilitating diseases for which there are limited therapeutic options.

Item Type: Article
Date Deposited: 05 Dec 2017 00:45
Last Modified: 25 Jan 2019 00:45


Email Alerts

Register with OAK to receive email alerts for saved searches.